首页> 外文期刊>Polski Przegland Chirurgiczny >Risk Factors Of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography – A Retrospective Cohort Study
【24h】

Risk Factors Of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography – A Retrospective Cohort Study

机译:内镜逆行胰胆管造影术后胰腺炎的危险因素–一项回顾性队列研究

获取原文
       

摘要

Endoscopic retrograde cholangiopancreatography (ERCP) is the most important non-surgical procedure in serious pancreatic and biliary diseases, still burdened with the risk of severe complications. The objective of the study was to distinguish factors which could increase the risk of occurrence of ERCP complication in the form of pancreatitis.Material and methods. The study included 452 patients who had undergone ERCP. Patients’ records were retrospectively analyzed from the aspect of demographic data, indications for the procedure, type and course of the procedure, type and severity of complications, width of the common bile duct (CBD), concomitant diseases and administered medicines which might increase the risk of complications.Results. In 35 patients (7.7%) a complication occurred in the form of pancreatitis (AP). A severe course was confirmed in 11 patients (31%). Cholelithiasis constituted approximately 2/3 of indications for ERCP. AP after ERCP was significantly more often observed in the group of patients aged under 40 (22.9% vs 8.6%; p0.05). Narrow biliary ducts (3-8 mm) were the factor increasing the frequency of development of AP (25.9% vs 45%; p0.05). Death occurred in 5 patients (1.1%), including 4 patients (0.96%) in the group without complications, and in 1 patient (2.85%) with complicated AP.Conclusions. ERCP is a very valuable procedure in clinical treatment; however, it is burdened with the risk of complications, such as AP, bleeding, or duodenal perforation. A group especially exposed to the risk of complications in the form of AP are young patients aged under 40 with a narrow CBD.
机译:内镜逆行胰胆管造影(ERCP)是严重的胰腺和胆道疾病中最重要的非手术方法,仍然存在严重并发症的风险。本研究的目的是区分可能增加以胰腺炎形式发生ERCP并发症的风险的因素。材料与方法。该研究包括452名接受ERCP治疗的患者。从人口统计数据,手术适应症,手术类型和过程,并发症的类型和严重程度,胆总管宽度(CBD),伴随疾病和所用药物等方面回顾性分析患者的病历。发生并发症的风险。在35名患者(7.7%)中,以胰腺炎(AP)的形式发生了并发症。在11名患者中确认了严重的病程(31%)。胆石症约占ERCP适应症的2/3。 ERCP后的AP在40岁以下的患者组中更为常见(22.9%对8.6%; p <0.05)。狭窄的胆管(3-8毫米)是增加AP发生频率的因素(25.9%vs 45%; p <0.05)。死亡发生在5例(1.1%)患者中,其中包括4例(0.96%)无并发症的患者和1例(2.85%)患有复杂AP的患者。 ERCP是临床治疗中非常有价值的程序。但是,它承受着并发症的风险,例如AP,出血或十二指肠穿孔。尤其容易遭受AP并发症风险的人群是40岁以下,CBD狭窄的年轻患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号